Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
Advancements in cellular and Molecular Medicine
- Molecular Medicine 2019

About Conference

 20th International Conference on Cellular and Molecular Medicine is scheduled on October 14-15 of 2019, at Rome, Italy.

Molecular Medicine 2019 is enlightened with a theme: "Advancements in cellular and Molecular medicine” provides a distinguished platform for all the Participants around the globe to enlighten the subject and the developments.


Molecular medicine invites all the delegates across the world to take part in the conference and make the way for a successful conference. Cellular and Molecular Medicine 2019 mainly focuses on the developing trends and advances in the field of Molecular Medicine, Cellular Medicine and its allied research areas.


“Cellular and Molecular Medicine conference” provides a valuable platform to discuss and learn about


  • Cellular and Molecular Medicine
  • Molecular Drug Designing
  • Medical diagnosis
  • Cellular medicine
  • Stem cell Biology
  • Molecular and Cellular Aspects in Diabetes
  • Nuclear Medicine & Molecular Imaging:
  • Tissue Engineering
  • Metabolomics
  • Pathology & Immunotherapy
  • Clinical and Translational Research
  • Biochemistry and Molecular Biology
  • Molecular Virology
  • Molecular pathology


2019 Highlights:

100+Participations

10+Keynote Speakers

50+Plenary Speakers

20+Exhibitors

5 Workshops


Targeted audience:


      • Department of Molecular Medicine
      • Department of Cell and Tissue Engineering
      • Clinical Researchers, Professors, Associate Professors, Assistant Professors
      • Ph.D. Scholars, Graduates and Post Graduates
      • Directors, CEO’s of Organizations
      • Association Presidents, Vice Presidents, and Professionals
      • Noble laureates in Health Care and Medicine
      • Pharmaceutical development companies
      • Research Institutes and members
      • Medical devices Manufacturing Companies
      • Training Institutes
      • Business Entrepreneurs

      Participation Benefits

      • All accepted abstracts will be published in the respective International supporting Journals
      • Each abstract will receive a (DOI) Number provided by CrossRef
      • All attendees will receive individual certification
      • Special privileges on group registrations
      • Networking with Experts in the Field
      • Live Streaming of your presentation through our websites and YouTube
      • Best Poster Competitions and Young Researcher Competitions among students all over the world
      • The Career Guidance Workshops to the Graduates, Doctorates and Post-Doctoral Fellows
      • Chance of B2B meeting
      • Opportunity to organize Workshop/Symposia
      • Opportunity to collaborate with our event
      • Avail the opportunity to organize pre-conference workshop
      • Individual momentous will be given to the Organizing Committee Members
      • Appreciation momentous will be awarded to the Moderators
      • Opportunity to interact with eminent personalities from all around the globe
      • Handbook and conference kit
      • 60% discount on manuscript publication


      Motives to attend:

      • Keynote presentations along with interactions to galvanize the scientific community.
      • Workshop and symposiums to reach the largest assemblage of participants from the Cellular and Molecular Medicine Communities and Associations.
      • A wide track of exhibitors to showcase new and emerging technologies.
      • Platform to the global investment community to connect with stakeholders in the pharma sector.
      • Young Scientist/ Investigators Award geared towards best budding young research.
      • Links to political marketing resources in order to expand your business and research network.
      • Triumph of Awards, Certificates recognizes your commitment to your profession to encourage nascent research.

      Welcome Message

      Allied Academies organize a conference Cellular and Molecular Medicine Conference during October 14-15, 2019 at Rome, Italy  with theme “Advancements in Cellular and Molecular Medicine”.

      Allied Academies is one of the leading organizers and Open access publishers of international scientific events and conferences every year across Europe, USA and Asia. Allied Academies has organized 3000+ worldwide Events with over, 600+ Conferences, 1200+ Symposiums, and 1200+ Workshops on pharmaceutical company, Engineering, Technology, Science, Medical and Business with 700+ peer-reviewed open access Journals in basic science, health, and technology.

      Cellular and Molecular Medicine Conference is for the gathering of Professors, researchers, clinicians, students of medicines and pharmacy, business tycoons and technocrats to display their recent research and talk about new thoughts, improvement and progresses in the field of Cellular, Molecular Medicine, basic clinical research, pre-clinical research, Genetics, Tissue Engineering, advancement in treatment and diagnosis or relieving symptoms of diseases, present and future challenge of Cellular and Molecular Medicine, social and cultural aspect of Molecular Medicine Researches.

      Sessions

      Cellular and Molecular Medicine: 

      The molecular and cellular medicine portfolio focuses on basic biological mechanisms or technologies relevant to human health and disease, including understanding the aetiology of disease and developing treatments. This includes specific responsibility for the MRC’scancer research portfolio, including basic biology, epidemiology and early translational research. Encompasses all fundamental and molecular aspects of Medicine. 

       

      Molecular Drug Designing:

      Drug design, frequently alluded to as reasonable medication outline or essentially normal plan, is the innovative procedure of finding new pharmaceuticals considering the information of a natural target. The medication is most generally a natural little atom that actuates or restrains the capacity of a bio molecule. for example, a protein, which thus brings about a remedialadvantage to the patient. In the most essential sense, medicate configuration includes the outline of particles that are corresponding fit as a fiddle and charge to the bio molecular focus with which they collaborate and in this way, will tie to it. Medication outline much of the time however not really depends on PC displaying systems.


      Medical Diagnosis:

      It is the way toward figuring out which illness or condition clarifies a man's side effects and signs. It is frequently alluded to as determination with the restorative setting being certain. The data required for finding is commonly gathered from a history and physical examination of the individual looking for restorative care. Frequently, at least one analyticmethodology, for example, indicative tests, are likewise done amid the procedure. Once in a while after death finding is viewed as a sort of restorative analysis.

       

      Cellular Medicine:

      Cell Medicine is another logical idea presented by Dr. Matthias Rath which clarifies that the essential driver of the present most basic interminablemaladies including different types of cardiovascular infections, diabetes, disease, and others, is a consequence of constant inadequacy of vitamins, amino acids and other particular supplements.

      At no other time was the inadequacy of cell bio-vitality and bio-strength portrayed as the essential driver of a whole gathering of infections.

      Cell Medicine characterizes an ideal every day admission of particularmicronutrients as a fundamental protection measure for looking after wellbeing, and successful and safe control of numerous obsessive conditions.

       

      Stem Cell Biology:

      Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use

      Stem cells are undifferentiated biological cells that have the potential to become specialized into different types of cells. Stem cell therapy can be used to prevent or cure several vital diseases like Parkinson’s disease, heart disease, spinal cord injury, etc. Stem Cell Medicine plans to play an active role in guiding and shaping the future of the pharmaceutical industry, now entering the era of personalized medical treatments. Customized medicine will largely depend on cell therapy and stem-cell combinations. Stem Cell Medicine intends to contribute significantly to the industry’s leap from current stem-cell R&D practices, technology and first-stage product development to pharmaceutical solutions.



      Molecular and Cellular Aspects in Diabetes:

      Diabetes mellitus portrayed by hyperglycemia is a gathering of metabolic maladies caused by lopsided direction of the flagging falls that intervenes insulin activity in the phone, imperfection of insulin discharge or both. The insulin-like development factors (IGFs) and their receptors and restricting proteins constitute a group of cell modulators that assume basic parts in the control of development and improvement. The IGF ligands incorporate three fundamentally related peptides: insulin, IGF-I, and IGF-II.

      Genes contain your DNA — the code that controls much of your body's form and function, from making you grow taller to regulating your body systems. Genes that don't work properly can cause disease.

      Gene therapy replaces a faulty gene or adds a new gene in an attempt to cure disease or improve your body's ability to fight disease. Gene therapy holds promise for treating a wide range of diseases, such as cancer, cystic fibrosis, heart disease, diabetes, hemophilia and AIDS.

      Researchers are still studying how and when to use gene therapy. Currently, in the United States, gene therapy is available only as part of a clinical trial.

       

      Nuclear Medicine & Molecular Imaging:

      Sub-atomic imaging is a kind of medicinal imaging that gives point by point pictures of what is going on inside the body at beams, figured tomography(CT) and ultrasound—offer pictures of physical structure, sub-atomic imaging enables doctors to perceive how the body is working and to quantify its synthetic and the sub-atomic and cell level. Where other indicative imaging systems, for example, x-organic procedures.

       

      Tissue Engineering:

      Tissue engineering is a rising multidisciplinary field that uses a blend of cells, building materials and biochemical elements to enhance or supplant natural capacities which thus enhance the wellbeing and personal satisfaction for many individuals worldwide by reestablishing, keeping up, or improving tissue and organ work. Tissue designing advanced from the field of biomaterials improvement and alludes to the act of consolidating platforms, cells, and organically dynamic particles into utilitarian tissues. The objective of tissue designing is to amass useful develops that reestablish, keep up, or enhance harmed tissues or entire organs. Fake skin and ligament are cases of designed tissues that have been affirmed by the FDA; notwithstanding, at present they have restricted use in human patients Tissue Engineering. 

       

      Metabolomics;

      Metabolomics is the scientific study of chemical processes involving metabolites, the small molecule intermediates and products of metabolism. Specifically, metabolomics is the "systematic study of the unique chemical fingerprints that specific cellular processes leave behind", the study of their small-molecule metabolite profiles. The metabolome represents the complete set of metabolites in a biological cell, tissue, organ or organism, which are the end products of cellular processes. mRNA gene expression data and proteomic analyses reveal the set of gene products being produced in the cell, data that represents one aspect of cellular function. Conversely, metabolic profiling can give an instantaneous snapshot of the physiology of that cell, and thus, metabolomics provides a direct "functional readout of the physiological state" of an organism. One of the challenges of systems biology and functional genomics is to integrate genomics, transcriptomic, proteomic, and metabolomic information to provide a better understanding of cellular biology.

       

      Pathology & Immunotherapy:

      Pathology is a gigantic piece of the therapeutic sciences to appreciate the possibility of the disease and an imperative field in conclusion and present day remedy. It joins a broad assortment of restorative practices and bioscience research to investigate disease generally by separating cells, tissues and body fluids. Nuclear arrangement is a rising domain that way to understand the sub-nuclear determinants of ailment and prosperity for the neutralizingactivity, finding and treatment using physical, substance, common and therapeutic procedures. The Department of Pathology and Molecular Medicine is a clinical office with an imperative research focus in tumor, hemostasis and vascular science. Understudies thusly have opportunities to look for after sweeping planning in fundamental and translational biomedical research, a case being symptomatic, perceptive and prognostic biomarker explore. The graduate undertakings offer opportunities to look for in the wake of bleeding edge degrees under the supervision of a great social event of major, clinical and translational investigators.

      Due to rapidly advancing field of cancer immunology in past few years, there has been production of several new methods of treating cancer called Immunotherapies. Immunotherapy is a type of treatment that increases the strength of immune response against tumors either by stimulating the activities of specific components of immune system or by counteracting signals produced by cancer cells that suppress immune responses. Some types of immunotherapy are also called as biologic therapy or biotherapy. Recent advancements in cancer immunotherapies have provided new therapeutic approaches. These include tumor-associated macrophages as treatment targets in oncology, in-situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy, immune checkpoint blockade and associated endocrinopathies and many more.

       

      Clinical and Translational Research:

      According to National Institute of Health (NIH), Clinical Research is defined in 3 ways i.e. (1) Patient oriented research. Research which is conducted with human subjects (or on material of human origin such as tissues, specimens and cognitive phenomena) for which an investigator (or colleague) directly interacts with human subjects. This definition excludes the in vitro studies that utilize human tissues that cannot be linked to a living individual. Patient oriented research involves: (a) therapeutic interventions, (b) mechanisms of human disease, (c) clinical trials, or (d) development of new technologies. (2) Epidemiological and behavioural investigations. (3) Outcomes research and health services research.

      Biochemistry and Molecular Biology:

      Biochemistry is the study of the structure and function of biologicalmolecules such as proteins, nucleic acids, carbohydrates and lipids. Biochemistry is also used to describe techniques suited to understanding the interactions and functions of biological molecules and it is a laboratory based science that brings together biology and chemistry. By using chemical knowledge and techniques, biochemists can understand and solve biological problems. Biochemistry focuses on processes happening at a molecular level and it focuses on what’s happening inside our cells. It also looks at how cells communicate with each other, for example during growth or fighting illness. Medicine is a broad category but relates to biochemistry on many levels. Doctors and nurses give drugs to patients to help cure a disease or prevent it. This is since when that drug is added to the human system, it alters how other chemicals in the body function, resulting in disease prevention or recovery.

       

      Molecular Virology:

      The mission of the Molecular Virology is to facilitate the acquisition of new insights into virus biology and cellular function through the study of viruses and to develop novel approaches

      An effective immune response can eliminate most viruses from the body and thus most viral infections are short lived. However, there are certain viruses that can evade the immune response and establish persistent infections in their host. The most famous example of such a virus is HIV, but there are many others. Viruses use a variety of strategies to evade the immune system. overall, these persistent infections are asymptomatic and only manifest clinically if the patient becomes immuno-compromised.to inhibit viral infection or treat viral diseases.


      Molecular Pathology:

      Molecular pathology is an emerging discipline within pathology which is focused in the study and diagnosis of disease through the examination of molecules within organs, tissues or bodily fluids. Molecular pathology shares some aspects of practice with both anatomic pathology and clinical pathology, molecular biology, biochemistry, proteomics and genetics, and is sometimes considered a "crossover" discipline. It is multi-disciplinary in nature and focuses mainly on the sub-microscopic aspects of disease. A key consideration is that more accurate diagnosis is possible when the diagnosis is based on both the morphologic changes in tissues (traditional anatomicpathology) and on molecular testing.

      Market Analysis

      Importance and Scope:

      Cellular medicine

      “Stem Cell Research and Regenerative Medicine” is an important field since human development takes place through stem cells. The complete understanding of their unique properties and control mechanisms can give an insight into early human development. Metabolic or physiological diseases such as cancer are thought to result from the abnormal behavior of cells. This means that a clear understanding of where things go 'wrong' in stem cell division can give a clear picture about cancer and can aid in realizing the ways to prevent the dysfunctional changes in the body or to introduce effective ways to treat them with targeted drugs. Stem cell application in regenerative medicine and tissue engineering is an alternative therapy for various diseases and the on-going extensive research in this field is assumed to further steer the medical applications of stem cells in upcoming years.

       

      Tissue engineering: 

      It accounted for the highest share in industrial development once they participate nationwide or geographically within the field of producing regenerative medicines. When we look into the geographic distribution of tissue engineering companies and research institutes, the U.S.A with 52 leads the market followed by Germany (21%), Japan (16%), the United Kingdom (7%), and Sweden (4%).

       

      The global tissue engineering and regeneration market reached $17 billion in 2013. This market is expected to grow to nearly $20.8 billion in 2014 and $56.9 billion in 2019, a compound annual growth rate (CAGR) of 22.3%.

      Today’s Market Study of Tissue Engineering and Regenerative Medicine in USA, Europe, Middle East and Asia Pacific

      USA: The global regenerative medicine market size is predicted to reach USD 49.41 billion by the year 2021.North America contributed the biggest share in the worldwide regenerative medicines market and was overwhelmed by the U.S.A.

      Europe: The worldwide tissue engineering and regeneration market came to $17 billion in 2013. This market is anticipated to grow to almost $20.8 billion in 2014 and $56.9 billion in 2019.

      Middle East: The Middle East and Africa regenerative medicines market is expected to achieve USD 5.75 billion by 2021 from USD 2.03 billion in 2016, developing at a CAGR of 23.15% amid the estimate time frame 2016-2021. Regenerative medicines repair, replace or regenerate human cells, tissues, or organs affected due to injury, aging processes, congenital defects, and damage due to trauma.

      Asia-Pacific: Asia-Pacific regenerative medicines market is relied upon to achieve UUSD 10.71 billion by 2021 from USD 3.01 billion in 2016, developing at a CAGR of 28.90% during the time period 2016-2021. Cell-based products sector is estimated to account for larger share of Asia-Pacific regenerative medicines market by product in 2016.

      Tissue Science is expected to be the fastest emerging technology because of the tremendous potential of gene therapy in minimizing immune rejections, which commonly occur after transplantations. Asia-Pacific would be the fastest growing region for regenerative medicine market. Europe and North America together accounted for over 3/4th of the market revenue and anticipated to be a most profitable regional market.      

      Worldwide Tissue Science Societies:

      • Australasian Society for Biomaterials and Tissue Engineering
      • European Society for Artificial Organs
      • European Association of Tissue Banks
      • German Society of Anti-Aging Medicine
      • International Federation for Artificial Organs
      • Tissue Engineering and Regenerative Medicine International Society
      • American Academy of Anti-Aging Medicine
      • Tissue and Cell Engineering Society (TCES)
      • Korean Tissue Engineering and Regenerative Medicine Society
      • Japanese Society for Tissue Engineering


      STEM CELLS MARKET OVERVIEW

      Globally Regenerative Medicines market size is predicted to reach USD 30,237 million by 2022. Recently, regenerative Medicine has emerged with full of promise approaches to treat and cure complex degenerative disorder and to support, restore the function of tissues and cells in other therapies. North America lead the way of global market in 2015 and it is expected to remain ascendant during 2015-2022. Stem Cells are used to treat cancer and different immune system diseases.


      Organizing Committee
      OCM Member
      Haruo Sugi
      Chairman of Muscle Committee in the International Union of Physiological Sciences
      The university of Tokyo
      Bunkyo, Japan
      OCM Member
      Vladislav S. Baranov
      Member of Russian Academy of Sciences, Saint-Petersburg, Russia
      Ott’s Institute of Obstetrics,Gynecology and Reproductology
      Saint Petersburg, Russia
      OCM Member
      Dr.Emmanual Loeb
      Senior Pathologist, CEO and Founder at Patho-Logica
      Utrecht University
      Amsterdam, Netherlands
      OCM Member
      John Yu
      Chair Professor/Director, Stem Cell/Translational Cancer Research
      Institute of Stem Cell/Translational Cancer Research, CGMH
      Hsinchu, Taiwan
      OCM Member
      Dr Yung-Feng Liao
      PhD in Biochemistry and Molecular Biology
      Kaohsiung Medical University
      Taipei City, Taiwan
      OCM Member
      Segundo Mesa Castillo
      Specialist in Neurology, Specialist in Neurology
      Psychiatric Hospital of Havana, Cuba
      Havana, Cuba
      OCM Member
      Marcos Roberto Tovani Palone
      University of São Paulo
      Sao Paulo, Brazil
      OCM Member
      Giulio Tarro
      President
      Foundation de Beaumont Bonelli for cancer research
      Naples, Italy
      OCM Member
      Dr Farid Menaa
      Professor, Director and Independent Consultant, Departments of Internal Medicine and Nanomedicine
      California Innovations Corporation
      Los Angeles, USA
      OCM Member
      Samer Ellahham
      Chief Quality Officer, Cardiologist and Vascular Consultant , Senior Cardiovascular Consultant
      Sheikh Khalifa Medical City
      Dubai, United Arab Emirates
      OCM Member
      Dr.Ahmed G Hegazi
      Professor, Microbiology and Immunology
      National Research Center
      Cairo, Egypt
      OCM Member
      Abdeen Mustafa Omer
      Researcher at Ministry of Health and Social Welfare
      Ministry of Health and Social Welfare
      Al-Gamaa Ave, Sudan
      OCM Member
      Dr. H. Fai Poon
      President, Bioanalytical Chemistry
      Quacell Biotechnology Ltd
      Gungzhou, China
      Venue
      &
      Hospitality

      The Conference Venue and Dates are as mentioned below:


      Venue: Holiday Inn Rome Aurelia

      Via Aurelia km 8,400   00165 ROMA


      Dates: 14th & 15th  October 2019

      Join The Discussion

      Allied Academies Global Conference Directory

      Mail us at

      Regarding Conference Info ( WhatsApp )
      molecularmedicine@alliedsummit.net
      For Registration
      molecularmedicine@alliedscholars.com
      For Sponsors / Exhibiting / Advertising
      molecularmedicine@alliedscholars.net
      More details about sponsorship:sponsors@alliedacademies.com

      Terms and Conditions

      Responsibility

      The organizers holds no responsibilities or liabilities of the personal articles of attendees at the venue against any kind of theft, lost, damage, due to any reason whatsoever. Delegates are entirely responsible for the safety of their own belongings.

       

      Insurance

      No insurance, of any kind, is included along with the registration in any of the events of the organization.

       

      Transportation

      Please note that transportation and parking is the responsibility of the registrant, Allied Academies will not be liable for any actions howsoever related to transportation and parking.

       

      Press/Media

      Press permission must be obtained from Allied Academies Conference Organizing Committee prior to the event. The press will not quote speakers or delegates unless they have obtained their approval in writing. The Allied Academies is an objective third-party non-profit organization and this conference is not associated with any commercial meeting company.

       

      Requesting an Invitation Letter

      For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference after payment of complete registration fee. Once registration is complete, please contact molecularmedicine@alliedscholars.com to request for a personalized letter of invitation, if not received until one month before the scheduled date of event.

      All the bank charges applicable during refund will be deducted from the account of participant.

       

      Cancellation Policy

      All cancellations or modifications of registration must be made in writing to finance@alliedacademies.com

      If, due to any reason, Allied academies postpone an event on the scheduled date, the participant is eligible for a credit of 100% of the registration fee paid. This credit shall only be used for another event organized by Allied academies within period of one year from the date of rescheduling.

       

      Postponement of event

      If, due to any reason, Allied academies postpone an event and the participant is unable or unwilling to attend the conference on rescheduled dates, he/she is eligible for a credit of 100% of the registration fee paid. This credit shall only be used for another event organized by Allied academies within period of one year from the date of rescheduling.

       

      Transfer of registration

      All registrations, after payment of complete registration fee, are transferable to other persons from the same organization, if in case the person is unable to attend the event. Request for transfer of registration must be made by the registered person in writing to contact@alliedacademies.com . Details must include the full name of replaced new registrant, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

      Registration can be transferred to one conference to another conference of Allied academies if the person is unable to attend one of conferences.

      However, Registration cannot be transferred if intimated within 14 days of respective conference.

      The transferred registrations will not be eligible for Refund.

      This cancellation policy was last updated on April 04, 2015.

       

       

      Visa Information

      Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

      Allied academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.

      Important note for failed visa applications: Visa issues are not covered under the cancellation policy of Allied academies, including the inability to obtain a visa.

       

      Refund Policy:

      If the registrant is unable to attend, and is not in a position to transfer his/her participation to another person or event, then the following refund policies apply:

      Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overhead charges, following Refund Policy Orders are available:

      • Before 60 days of the conference: Eligible for Full Refund after deduction of $100 towards service Fee.
      • Within 60-30 days of Conference: Eligible for 50% of payment Refund
      • Within 30 days of Conference: Not eligible for Refund
      • E-Poster Payments will not be refunded.

       

      Accommodation Cancellation Policy:

      Accommodation Service Providers (Hotels) have their own cancellation policies which are applicable when cancellations are made less than 30 days prior to arrival. If in case the registrant wishes to cancel or amend the accommodation, he/ she is expected to inform the organizing authorities on a prior basis. Allied academies will advise the registrant to ensure complete awareness about the cancellation policy of your accommodation provider, prior to cancellation or modification of their booking

       

       

      Authorization Policy

      Copyright © 2019-2020 Allied Academies, All Rights Reserved.